44 related articles for article (PubMed ID: 29779859)
1. Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing.
Braun SA; Baran J; Schrumpf H; Buhren BA; Bölke E; Homey B; Gerber PA
Eur J Med Res; 2018 Sep; 23(1):45. PubMed ID: 30266096
[TBL] [Abstract][Full Text] [Related]
2. Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.
Voigt AY; Emiola A; Johnson JS; Fleming ES; Nguyen H; Zhou W; Tsai KY; Fink C; Oh J
J Invest Dermatol; 2022 Oct; 142(10):2773-2782.e16. PubMed ID: 35390349
[TBL] [Abstract][Full Text] [Related]
3. Ingenol mebutate-associated immune thrombocytopenic purpura.
Zuberi H; Amin SA
JAAD Case Rep; 2024 Apr; 46():30-32. PubMed ID: 38510842
[No Abstract] [Full Text] [Related]
4. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
Erlendsson AM
Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
[TBL] [Abstract][Full Text] [Related]
5. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
6. Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment?
Maglie R; Grandi V; Maio V; Pileri A
G Ital Dermatol Venereol; 2018 Jun; 153(3):442-443. PubMed ID: 29766707
[No Abstract] [Full Text] [Related]
7. Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases.
Moreno Romero JA; Campoy A; Perez N; Garcia F; Grimalt R
Br J Dermatol; 2015 Dec; 173(6):1514-7. PubMed ID: 26227007
[TBL] [Abstract][Full Text] [Related]
8. [Rapidly growing squamous cell carcinoma after ingenol mebutate treatment].
Ehret M; Velter C; Tebacher M; Bruant-Rodier C; Cribier B
Ann Dermatol Venereol; 2018 Oct; 145(10):607-612. PubMed ID: 29779859
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
Berman B
Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
[TBL] [Abstract][Full Text] [Related]
10. Ingenol mebutate: a new option for actinic keratosis treatment.
Gras J
Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
Stockfleth E; Bastian M
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
